IL17A and Guillain-Barre syndrome: Th17 and Th22 cells of GBS patients at acute phase could express an appropriate cytokine profile, like IL-17, IL-22, and others (IL-6 and TNF-α), which can enhance the inflammatory and autoimmune response and conduce to the development of GBS [33, 34].